Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Leflunomide and methotrexate are similarly effective for rheumatoid arthritis but have different side effects.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

A woman with a rare type of dermatomyositis improved with low-dose prednisone and methotrexate.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.

Many patients on methotrexate experience significant side effects but still continue the medication.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

Dermoscopy helps diagnose folliculotropic mycosis fungoides by identifying specific skin patterns.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Early diagnosis and treatment are crucial for managing Folliculotropic Mycosis Fungoides on the scalp.

A 308 nm excimer laser successfully treated a boy with a rare skin condition after about a year of weekly sessions.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Betamethasone dipropionate reduced skin thickness, fish oil increased it, and combined treatment had no significant effect.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

Researchers developed a new skin patch that delivers more finasteride into the skin, potentially improving treatment for hair loss and prostate issues.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Some cases of folliculotropic mycosis fungoides may progress slowly and not need aggressive treatment.

Tofacitinib may effectively treat folliculitis decalvans.

Mycosis fungoides can have unusual symptoms and may be misdiagnosed, but specific cell markers might suggest a lower risk of worsening.